New Evidence Shows Medication Can Reverse Multiple Sclerosis.
Originally Published 2 years ago — by Medical Xpress
Researchers have developed a technique to measure the effectiveness of clemastine, an over-the-counter antihistamine, in repairing the brain of patients with multiple sclerosis (MS). Using MRI scans, they found that patients treated with clemastine experienced modest increases in myelin water, indicating myelin repair. The myelin water fraction technique could be used to track myelin recovery and set the standard for future research into remyelinating therapies. Clemastine works by stimulating the differentiation of myelin-making stem cells, making it a generation ahead of existing MS drugs. Future research will examine clemastine's potential in treating brain injury in premature infants.